It’s not clear whether patients with type 2 diabetes gain any long-term benefit from taking the blood sugar-lowering drug metformin and insulin together rather than insulin alone. That’s the conclusion of Danish researchers who reviewed data from 23 clinical trials involving more than 2,200 patients over the age of 18.
